277 related articles for article (PubMed ID: 26041746)
1. Tissue Transglutaminase Mediated Tumor-Stroma Interaction Promotes Pancreatic Cancer Progression.
Lee J; Condello S; Yakubov B; Emerson R; Caperell-Grant A; Hitomi K; Xie J; Matei D
Clin Cancer Res; 2015 Oct; 21(19):4482-93. PubMed ID: 26041746
[TBL] [Abstract][Full Text] [Related]
2. Tissue Transglutaminase Activates Cancer-Associated Fibroblasts and Contributes to Gemcitabine Resistance in Pancreatic Cancer.
Lee J; Yakubov B; Ivan C; Jones DR; Caperell-Grant A; Fishel M; Cardenas H; Matei D
Neoplasia; 2016 Nov; 18(11):689-698. PubMed ID: 27792935
[TBL] [Abstract][Full Text] [Related]
3. Inhibiting YAP expression suppresses pancreatic cancer progression by disrupting tumor-stromal interactions.
Jiang Z; Zhou C; Cheng L; Yan B; Chen K; Chen X; Zong L; Lei J; Duan W; Xu Q; Li X; Wang Z; Ma Q; Ma J
J Exp Clin Cancer Res; 2018 Mar; 37(1):69. PubMed ID: 29587800
[TBL] [Abstract][Full Text] [Related]
4. Tissue transglutaminase inhibits autophagy in pancreatic cancer cells.
Akar U; Ozpolat B; Mehta K; Fok J; Kondo Y; Lopez-Berestein G
Mol Cancer Res; 2007 Mar; 5(3):241-9. PubMed ID: 17374730
[TBL] [Abstract][Full Text] [Related]
5. GM-CSF Mediates Mesenchymal-Epithelial Cross-talk in Pancreatic Cancer.
Waghray M; Yalamanchili M; Dziubinski M; Zeinali M; Erkkinen M; Yang H; Schradle KA; Urs S; Pasca Di Magliano M; Welling TH; Palmbos PL; Abel EV; Sahai V; Nagrath S; Wang L; Simeone DM
Cancer Discov; 2016 Aug; 6(8):886-99. PubMed ID: 27184426
[TBL] [Abstract][Full Text] [Related]
6. Key players in pancreatic cancer-stroma interaction: Cancer-associated fibroblasts, endothelial and inflammatory cells.
Nielsen MF; Mortensen MB; Detlefsen S
World J Gastroenterol; 2016 Mar; 22(9):2678-700. PubMed ID: 26973408
[TBL] [Abstract][Full Text] [Related]
7. Blocking CTGF-Mediated Tumor-Stroma Interplay in Pancreatic Cancer.
Shen YW; Zhou YD; Luan X; Zhang WD
Trends Mol Med; 2020 Dec; 26(12):1064-1067. PubMed ID: 32928643
[TBL] [Abstract][Full Text] [Related]
8. Kaempferol induces ROS-dependent apoptosis in pancreatic cancer cells via TGM2-mediated Akt/mTOR signaling.
Wang F; Wang L; Qu C; Chen L; Geng Y; Cheng C; Yu S; Wang D; Yang L; Meng Z; Chen Z
BMC Cancer; 2021 Apr; 21(1):396. PubMed ID: 33845796
[TBL] [Abstract][Full Text] [Related]
9. Tumor-stroma interaction in orthotopic primary pancreatic cancer xenografts during hedgehog pathway inhibition.
Chang Q; Foltz WD; Chaudary N; Hill RP; Hedley DW
Int J Cancer; 2013 Jul; 133(1):225-34. PubMed ID: 23280784
[TBL] [Abstract][Full Text] [Related]
10. Tissue transglutaminase regulates focal adhesion kinase/AKT activation by modulating PTEN expression in pancreatic cancer cells.
Verma A; Guha S; Wang H; Fok JY; Koul D; Abbruzzese J; Mehta K
Clin Cancer Res; 2008 Apr; 14(7):1997-2005. PubMed ID: 18381937
[TBL] [Abstract][Full Text] [Related]
11. Conformational changes and translocation of tissue-transglutaminase to the plasma membranes: role in cancer cell migration.
Kumar A; Hu J; LaVoie HA; Walsh KB; DiPette DJ; Singh US
BMC Cancer; 2014 Apr; 14():256. PubMed ID: 24725450
[TBL] [Abstract][Full Text] [Related]
12. Transglutaminase 2 on the surface of dendritic cells is proposed to be involved in dendritic cell-T cell interaction.
Kim JH; Jeong EM; Jeong YJ; Lee WJ; Kang JS; Kim IG; Hwang YI
Cell Immunol; 2014; 289(1-2):55-62. PubMed ID: 24727157
[TBL] [Abstract][Full Text] [Related]
13. Tissue transglutaminase-2 promotes gastric cancer progression via the ERK1/2 pathway.
Wang X; Yu Z; Zhou Q; Wu X; Chen X; Li J; Zhu Z; Liu B; Su L
Oncotarget; 2016 Feb; 7(6):7066-79. PubMed ID: 26771235
[TBL] [Abstract][Full Text] [Related]
14. Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-kappaB activity in hypoxic tumor cells.
Jang GY; Jeon JH; Cho SY; Shin DM; Kim CW; Jeong EM; Bae HC; Kim TW; Lee SH; Choi Y; Lee DS; Park SC; Kim IG
Oncogene; 2010 Jan; 29(3):356-67. PubMed ID: 19838207
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia triggers hedgehog-mediated tumor-stromal interactions in pancreatic cancer.
Spivak-Kroizman TR; Hostetter G; Posner R; Aziz M; Hu C; Demeure MJ; Von Hoff D; Hingorani SR; Palculict TB; Izzo J; Kiriakova GM; Abdelmelek M; Bartholomeusz G; James BP; Powis G
Cancer Res; 2013 Jun; 73(11):3235-47. PubMed ID: 23633488
[TBL] [Abstract][Full Text] [Related]
16. Stroma secreted IL6 selects for "stem-like" population and alters pancreatic tumor microenvironment by reprogramming metabolic pathways.
Kesh K; Garrido VT; Dosch A; Durden B; Gupta VK; Sharma NS; Lyle M; Nagathihalli N; Merchant N; Saluja A; Banerjee S
Cell Death Dis; 2020 Nov; 11(11):967. PubMed ID: 33177492
[TBL] [Abstract][Full Text] [Related]
17. Tissue transglutaminase (TG2) is involved in the resistance of cancer cells to the histone deacetylase (HDAC) inhibitor vorinostat.
Carbone C; Di Gennaro E; Piro G; Milone MR; Pucci B; Caraglia M; Budillon A
Amino Acids; 2017 Mar; 49(3):517-528. PubMed ID: 27761756
[TBL] [Abstract][Full Text] [Related]
18. Involvement of host stroma cells and tissue fibrosis in pancreatic tumor development in transgenic mice.
Spector I; Zilberstein Y; Lavy A; Nagler A; Genin O; Pines M
PLoS One; 2012; 7(7):e41833. PubMed ID: 22848627
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of naturally occurring transglutaminase 2 mutants implicated in early-onset type 2 diabetes.
Salter NW; Ande SR; Nguyen HK; Nyomba BL; Mishra S
J Mol Endocrinol; 2012 Jun; 48(3):203-16. PubMed ID: 22394545
[TBL] [Abstract][Full Text] [Related]
20. Activation of transglutaminase type 2 for aortic wall protection in a rat abdominal aortic aneurysm formation.
Munezane T; Hasegawa T; Suritala ; Tanaka A; Okada K; Okita Y
J Vasc Surg; 2010 Oct; 52(4):967-74. PubMed ID: 20615646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
